Page title

Tribal Opioid Response Grants

Main page content

Short Title
TOR
Initial Announcement
Notice of Funding Opportunity (NOFO)
NOFO Number
TI-22-006
Posted on Grants.gov
Application Due Date
Catalog of Federal Domestic Assistance (CFDA) Number
93.788
Description

The purpose of the TOR program is to assist in addressing the overdose crisis in Tribal communities by increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and co-occurring substance use disorders. The TOR program also supports the full continuum of prevention, harm reduction, treatment and recovery support services for stimulant misuse and use disorders, including for cocaine and methamphetamine.

Eligibility

Eligibility is limited to federally recognized American Indian or Alaska Native Tribe or tribal organizations. Tribes and tribal organizations may apply individually, as a consortium, or in partnership with an Urban Indian Organizations.

Award Information
Funding Mechanism
Grant
Anticipated Total Available Funding
Up to $55,000,000
Anticipated Number of Awards
Up to 150 awards
Anticipated Award Amount
See Appendix L for distribution
Length of Project
Up to 2 years
Cost Sharing/Match Required?
No

Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Contact Information
Program Issues

William Longinetti
Office of Tribal Affairs and Policy
Substance Abuse and Mental Health Services Administration
(240) 276-1190
william.longinetti@samhsa.hhs.gov

Grants Management and Budget Issues

Olivia Cline-Thomas
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1413
olivia.clinethomas@samhsa.hhs.gov

Last Updated

Last Updated: 05/17/2022